JW Therapeutics
Manufacturing · China · 11-50 Employees
View Company Info for Free
Overview
Headquarters
666 Haike Road Pudong New Area, Shanghai...Phone Number
+86 2150783699Website
www.jndsd.comRevenue
$12.9 MillionIndustry
About JW Therapeutics
JW Therapeutics Org Chart
Is JW Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
JW Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once JW Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at JW Therapeutics
Earning: See what the market has to say on JW Therapeutics recently announced quarterly report
Check out if JW Therapeutics is spiking on competitors!
Product Launch: Get notified when JW Therapeutics launches new products
Check if JW Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if JW Therapeutics had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined JW Therapeutics as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
JW Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
JW Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about JW Therapeutics.
JW Therapeutics Tech Stack
JW Therapeutics News & Media
JW Therapeutics Announces Approval of Relmacabtagene Autoleucel Injection (Carteyva®) for Marketing in Macao
SHANGHAI, June 4, 2025 /PRNewswire/ -- JW Therapeutics (HKEx: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced that its new drugapplication (NDA) for the CAR-T cell immunotherapy product Carteyva® (relma-cel, targeting CD19) was approved by the Macao Special Administrative Region Government's Drug Regulatory Authority. This marks the first overseas market access for the product after its ap
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding JW Therapeutics
JW Therapeutics Co Ltd is a company that operates in the Pharmaceuticals industry. It employs 20to49 people and has 10Mto25M of revenue. The company is headquartered in Shanghai, Shanghai, China.... Read More